These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 31191511)

  • 1. Mast Cells and Their Progenitors in Allergic Asthma.
    Méndez-Enríquez E; Hallgren J
    Front Immunol; 2019; 10():821. PubMed ID: 31191511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating mast cell progenitors correlate with reduced lung function in allergic asthma.
    Salomonsson M; Malinovschi A; Kalm-Stephens P; Dahlin JS; Janson C; Alving K; Hallgren J
    Clin Exp Allergy; 2019 Jun; 49(6):874-882. PubMed ID: 30892731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of Histamine-releasing Factor in Allergic Inflammatory Reactions].
    Kashiwakura JI; Ando T; Kawakami T
    Yakugaku Zasshi; 2017; 137(5):517-521. PubMed ID: 28458281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgE immune complexes stimulate an increase in lung mast cell progenitors in a mouse model of allergic airway inflammation.
    Dahlin JS; Ivarsson MA; Heyman B; Hallgren J
    PLoS One; 2011; 6(5):e20261. PubMed ID: 21625525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of immunoglobulin E and mast cells in murine models of asthma.
    Mayr SI; Zuberi RI; Liu FT
    Braz J Med Biol Res; 2003 Jul; 36(7):821-7. PubMed ID: 12845367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell-IgE-and mast cell-structural cell interactions in allergic airway disease.
    Pawankar R; Yamagishi S; Takizawa R; Yagi T
    Curr Drug Targets Inflamm Allergy; 2003 Dec; 2(4):303-12. PubMed ID: 14561149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen cleavage products and Toll-like receptor 4 promote the generation of programmed cell death 1 ligand 2-positive dendritic cells in allergic asthma.
    Cho M; Lee JE; Lim H; Shin HW; Khalmuratova R; Choi G; Kim HS; Choi WS; Park YJ; Shim I; Kim BS; Kang CY; Kim JO; Tanaka S; Kubo M; Tung HY; Landers CT; Corry DB; Kheradmand F; Chung Y
    J Allergy Clin Immunol; 2018 Aug; 142(2):530-541.e6. PubMed ID: 29038008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease.
    Gomez G
    Front Immunol; 2019; 10():175. PubMed ID: 30792720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between mediator release from human lung mast cells in vitro and in vivo.
    Holgate ST; Benyon RC; Howarth PH; Agius R; Hardy C; Robinson C; Durham SR; Kay AB; Church MK
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):47-56. PubMed ID: 2409026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early activation of mucosal mast cells during the primary immune response in a rodent model of neonatal asthma.
    Liu S; Shudou M; Maeyama K
    Immunol Cell Biol; 2011 Feb; 89(2):239-45. PubMed ID: 20661260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine-releasing factor has a proinflammatory role in mouse models of asthma and allergy.
    Kashiwakura JC; Ando T; Matsumoto K; Kimura M; Kitaura J; Matho MH; Zajonc DM; Ozeki T; Ra C; MacDonald SM; Siraganian RP; Broide DH; Kawakami Y; Kawakami T
    J Clin Invest; 2012 Jan; 122(1):218-28. PubMed ID: 22133880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgE production in CD40/CD40L cross-talk of B and mast cells and mediator release via TGase 2 in mouse allergic asthma.
    Hong GU; Park BS; Park JW; Kim SY; Ro JY
    Cell Signal; 2013 Jun; 25(6):1514-25. PubMed ID: 23524335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-33 exacerbates allergic bronchoconstriction in the mice via activation of mast cells.
    Sjöberg LC; Gregory JA; Dahlén SE; Nilsson GP; Adner M
    Allergy; 2015 May; 70(5):514-21. PubMed ID: 25660244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgE and IgA produced by OX40-OX40L or CD40-CD40L interaction in B cells-mast cells re-activate FcεRI or FcαRI on mast cells in mouse allergic asthma.
    Hong GU; Lim JY; Kim NG; Shin JH; Ro JY
    Eur J Pharmacol; 2015 May; 754():199-210. PubMed ID: 25704619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide enhances FcεRI-mediated mast cell degranulation by increasing Ca2+ entry through store-operated Ca2+ channels: implications for lipopolysaccharide exacerbating allergic asthma.
    Yang C; Mo X; Lv J; Liu X; Yuan M; Dong M; Li L; Luo X; Fan X; Jin Z; Liu Z; Liu J
    Exp Physiol; 2012 Dec; 97(12):1315-27. PubMed ID: 22581748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated FcεRI triggering reveals modified mast cell function related to chronic allergic responses in tissue.
    Suurmond J; Habets KLL; Tatum Z; Schonkeren JJ; Hoen PAC'; Huizinga TWJ; Laros JFJ; Toes REM; Kurreeman F
    J Allergy Clin Immunol; 2016 Sep; 138(3):869-880. PubMed ID: 27033170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
    Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
    Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raf kinase inhibitor protein negatively regulates FcεRI-mediated mast cell activation and allergic response.
    Lin W; Su F; Gautam R; Wang N; Zhang Y; Wang X
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):E9859-E9868. PubMed ID: 30282734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthma and mast cell activation.
    Kaliner M
    J Allergy Clin Immunol; 1989 Feb; 83(2 Pt 2):510-20. PubMed ID: 2645347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor-mediated activation of mast cells: implications for allergic disease?
    Marshall JS; McCurdy JD; Olynych T
    Int Arch Allergy Immunol; 2003 Oct; 132(2):87-97. PubMed ID: 14600420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.